COMMUNIQUÉS West-GlobeNewswire

Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update
07/03/2019
- A4250 Phase 3 PFIC pivotal program on target for end of ‘19/early ’20 topline readout - - Plan to initiate second A4250 pivotal program in biliary atresia - - Plan to initiate Phase 2 study with elobixibat in NASH [...]
Centrexion Therapeutics Announces CNTX-4975 Preclinical and Clinical Data Presentations at the 35th Annual American Academy of Pain Medicine Meeting
07/03/2019
Company will present two posters on CNTX-4975 for treatment of moderate to severe knee osteoarthritis pain; pharmacological data from preclinical and Phase 1 and 2 clinical trials describing the mechanism of action; and [...]
XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights
07/03/2019
Added seven new partner-funded programs in 2018 with potential for milestone and royalty payments Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Calif., March 07, 2019 (GLOBE NEWSWIRE [...]
Ossur Hf : Board decisions following the Annual General Meeting
07/03/2019
Announcement no. 17/2019 7 March 2019 Board decisions following the Annual General Meeting Enclosed are the Board decisions following the Annual General Meeting of Össur hf. held today, Thursday 7 March 2019. Further [...]
Inivata Publishes Positive Results of Clinical Validation and Utility Study for InVision® Liquid Biopsy Test
07/03/2019
Inivata Publishes Positive Results of Clinical Validation and Utility Study for InVision ® Liquid Biopsy Test Large, real-world, prospective study shows Inivata’s liquid biopsy test is able to provide molecular profile [...]
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07/03/2019
WALTHAM, Mass. and CRESTWOOD, Ky., March 07, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Emerald Health Therapeutics’ Licensed Endo Product Wins Taste For Life’s 2019 Essentials Supplement Award in the U.S.
07/03/2019
Novel Emerald endocannabinoid-supporting products well-positioned to develop brand presence and market demand among both cannabis and non-cannabis users SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
HEXO Corp to announce second quarter fiscal 2019 results and conference call
07/03/2019
GATINEAU, Quebec, March 07, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ; NYSE-A: HEXO ) will release its financial results for the second quarter fiscal 2019 ended January 31 before [...]
HEXO Corp annonce ses résultats du deuxième trimestre de l’exercice 2019
07/03/2019
GATINEAU, Québec, 07 mars 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ; NYSE-A : HEXO ) publiera ses résultats financiers du deuxième trimestre de l’exercice 2019, clos le 31 janvier, et [...]
Exactus Announces Retirement of Remaining Convertible Notes
07/03/2019
GLEN ALLEN, Va., March 07, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced that it has retired the last of [...]
Achillion Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
- Phase 2 trial enrollment on schedule in PNH combo, interim data expected in Q2:2019 - - Phase 2 trial enrollment on schedule in C3G, 24 sites recruiting - - Next-generation factor D inhibitor ACH-5228 US IND [...]
Opthea’s Phase 2b Trial in Wet AMD Advances with a Second Positive Independent Safety Committee Recommendation
07/03/2019
MELBOURNE, Australia, March 07, 2019 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT) is pleased to announce that the independent Data and Safety Monitoring Board (DSMB) for the Company’s ongoing Phase 2b study of OPT-302 [...]
Ossur Hf : Results of the Annual General Meeting
07/03/2019
Announcement no. 16/2019 7 March 2019 Results of the Annual General Meeting Enclosed are the results of the Annual General Meeting of Össur hf. held today, Thursday 7 March 2019. The Icelandic Register of Enterprises [...]
111, Inc. Announces Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results
07/03/2019
SHANGHAI, China, March 07, 2019 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results [...]
Athenex Regains Rights to KX2-391 in China
07/03/2019
BUFFALO, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
BrainStorm to Host Business Update Conference Call
07/03/2019
Tuesday, March 12th at 8.30am EDT NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leader in developing innovative autologous cellular therapies for highly debilitating [...]
PDMR Dealing
07/03/2019
LONDON, March 07, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Helsinn initiates two new global Phase III studies with anamorelin
07/03/2019
Helsinn initiates two new global Phase III studies with anamorelin Helsinn committed to anamorelin which is being evaluated for weight loss and anorexia in patients with advanced non small cell lung cancer (NSCLC) and [...]
About acquisition of significant shareholding
07/03/2019
On 20th of February 20, 2019 JSC Olainfarm has received a notification by Signe Baldere-Sildedze natural guardian of shareholder Anna Emīlija Maligina regarding increased material shareholding up till 7.8% from share [...]

Pages